Related Experiment Video
Updated: May 23, 2026

04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
Image-Guided Excision of Oral Leukoplakia Using Narrow-Band Imaging Illumination and Two-Stage Local Anesthesia
1Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Keelung, Taiwan, Republic of China.
Summary
Narrow-band imaging (NBI) with a two-stage anesthesia protocol improves oral leukoplakia excision. This method enhances visualization and ensures complete lesion removal, reducing recurrence risk.
Area of Science:
- Oral Medicine
- Surgical Oncology
- Medical Imaging
Background:
- Oral leukoplakia requires complete excision to prevent malignant transformation.
- Standard local anesthesia can obscure lesion margins due to blanching.
- Accurate margin delineation is crucial for successful oral leukoplakia treatment.
Purpose of the Study:
- To evaluate narrow-band imaging (NBI) for guided excision of oral leukoplakia.
- To assess a two-stage local anesthesia protocol to overcome anesthetic-induced blanching.
- To determine the efficacy of NBI-guided excision in achieving complete lesion removal.
Main Methods:
- A two-stage local anesthesia protocol was employed: plain lidocaine followed by lidocaine with epinephrine.
- Excision margins were defined using narrow-band imaging (NBI) illumination with a carbon dioxide laser.
- Twenty-one patients with 50 oral leukoplakia lesions underwent NBI-guided excision.
Main Results:
- All surgical margins were confirmed to be free of residual oral leukoplakia disease.
- A low recurrence rate of one lesion was observed during follow-up.
- No malignant transformations were noted in any of the treated patients.
Conclusions:
- NBI-guided excision combined with two-stage local anesthesia effectively enhances visualization of oral leukoplakia.
- This technique facilitates precise margin delineation, leading to complete lesion removal.
- The approach shows promise for improving treatment outcomes and reducing recurrence in oral leukoplakia management.